- Home
- SSBI vs NXPLW Comparison
SSBI vs NXPLW Comparison
Compare SSBI & NXPLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSBI
- NXPLW
- Stock Information
- Founded
- SSBI 1982
- NXPLW N/A
- Country
- SSBI United States
- NXPLW United States
- Employees
- SSBI N/A
- NXPLW N/A
- Industry
- SSBI Major Banks
- NXPLW Telecommunications Equipment
- Sector
- SSBI Finance
- NXPLW Telecommunications
- Exchange
- SSBI Nasdaq
- NXPLW Nasdaq
- Market Cap
- SSBI N/A
- NXPLW N/A
- IPO Year
- SSBI 2006
- NXPLW N/A
- Fundamental
- Price
- SSBI $7.54
- NXPLW $0.21
- Analyst Decision
- SSBI
- NXPLW
- Analyst Count
- SSBI 0
- NXPLW 0
- Target Price
- SSBI N/A
- NXPLW N/A
- AVG Volume (30 Days)
- SSBI 19.0K
- NXPLW 6.4K
- Earning Date
- SSBI 01-28-2025
- NXPLW 03-31-2025
- Dividend Yield
- SSBI 2.12%
- NXPLW N/A
- EPS Growth
- SSBI N/A
- NXPLW N/A
- EPS
- SSBI N/A
- NXPLW N/A
- Revenue
- SSBI $25,783,000.00
- NXPLW $66,482,000.00
- Revenue This Year
- SSBI N/A
- NXPLW N/A
- Revenue Next Year
- SSBI N/A
- NXPLW N/A
- P/E Ratio
- SSBI N/A
- NXPLW N/A
- Revenue Growth
- SSBI N/A
- NXPLW 179.89
- 52 Week Low
- SSBI $5.68
- NXPLW $0.25
- 52 Week High
- SSBI $11.63
- NXPLW $0.26
- Technical
- Relative Strength Index (RSI)
- SSBI 56.22
- NXPLW N/A
- Support Level
- SSBI $6.95
- NXPLW N/A
- Resistance Level
- SSBI $7.65
- NXPLW N/A
- Average True Range (ATR)
- SSBI 0.20
- NXPLW 0.00
- MACD
- SSBI 0.02
- NXPLW 0.00
- Stochastic Oscillator
- SSBI 80.82
- NXPLW 0.00
About NXPLW NextPlat Corp
NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.